NEWSROOM
Former Merck USA President Joins Klotho Neurosciences’ Board of Directors
Highly Accomplished Pharmaceutical Leader, Riad El-Dada, Further Enhances Board Expertise NEW YORK, Dec. 03, 2024 - PRISM MediaWire - Klotho Neurosciences, Inc. (NASDAQ: KLTO), a U.S.-based biotechnology company pioneering cell and gene therapies for neurodegenerative and age-related disorders, including ALS, Alzheimer’s, and Parkinson’s, today announced the appointment of Riad El-Dada, former US President of Merck, to its Board of Directors. With decades of leadership in the pharmaceutical...
AB INTL Group Announces Repurchase of 300 Million Shares and Planning Spin-off of NFT MMM IP and AI Consulting Business
NEW YORK, Dec. 03, 2024 - PRISM MediaWire - AB International Group Corp. (OTC: ABQQ), an intellectual property (IP) and movie investment and licensing firm, today announced the Company entered into Repurchase Agreements with four shareholders, all non-affiliates of the Company, pursuant to which the Company agreed to repurchase shares of their Common Stock, $0.001 par value, amounting to 300,000,000 shares for cancellation. The price to be paid by the Company under the Repurchase Agreements is...
Lipella Pharmaceuticals Announces Publication in CUREUS on Non-Steroid Treatment of Oral Lichen Planus
Peer-reviewed article highlights potential treatment for OLP with focus on localized drug delivery PITTSBURGH, Dec. 03, 2024 - PRISM MediaWire - Lipella Pharmaceuticals Inc. (Nasdaq: LIPO), a clinical-stage biotechnology company dedicated to addressing serious diseases with significant unmet needs, today announced the publication of a peer-reviewed paper in CUREUS. Titled “Rationale for the Use of Topical Calcineurin Inhibitors in the Management of Oral Lichen Planus and Mucosal...
Oncocyte dd-cfDNA Assay Detects Kidney Transplant Rejection 11+ Months Ahead of Standard Protocols, New Study Affirms
Oncocyte first to published randomized interventional data to rule-in for biopsy in high-risk patient population Study shows that monitoring with Oncocyte’s assay significantly reduces time to rejection diagnosis in patients with newly developed donor-specific antibodies Early detection of transplant rejection is growing in significance as novel therapeutic treatments show promising early results in antibody mediated rejection. Study published in Nephrology Dialysis...
Halberd Update on WatchDawg® PTSD Treatment
Next Phase Pilot Study Jackson Center, PA, December 2, 2024 - PRISM MediaWire - Halberd Corporation (OTC PINK: HALB) previously reported results of a recently concluded initial 10-person Pilot Study of volunteer veterans suffering from PTSD and possible suicidal ideation. The results of that study can be found here. Based on the encouraging results of that initial pilot study, upgrades and enhancements to the data collection methodology, data analysis, hardware, software...
StemSation International Announces Acquisition of Gorilla Marketing Group, LLC
StemSation International announced today the completion of the acquisition of 100% of the private marketing company, Gorilla Marketing Group, LLC Strategic Acquisition Completed: StemSation International has finalized the acquisition of Gorilla Marketing Group (GMG), owner of the high-end AlienHouse vape product line. This move positions the company for significant growth in the THC-P vape and lifestyle product markets. Enhanced Market Presence: With GMG's established brand and innovative...
Skyborne Technology, Inc., a UAV Corp Company (UMAV) and Atlantic Industrial Group Inc. (AIG) Announce AI Manufacturing JV for VTOL & Lighter than Air Vehicles
Skyborne’s Costin Airport Grant Infrastructure Project Has Been Completed for The Near Future Build of New Hangar Cutting-Edge Manufacturing: AIG will produce high-efficiency drone models (SVTOLs) at Skyborne’s facility, leveraging innovative manufacturing techniques like large-scale 3D printing for airframe parts, wing structures, and cockpits Focus on Design and Innovation: An in-house design center will specialize in creating airships and drones using lightweight materials for superior...
SKYX to Present at Noble Capital Markets’ NobleCon20 on December 3, 2024
Rani Kohen, Founder, and Steve Schmidt, President of SKYX, to Present at 1:30 PM ET on December 3, 2024, and Engage in Investor Meetings Throughout the Conference MIAMI, Nov. 27, 2024 - PRISM MediaWire - SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a "SKYX Technologies"), a highly disruptive smart platform technology company with over 97 issued and pending patents in the U.S. and globally, and over 60 lighting and home décor websites with a mission to make homes and buildings become smart, safe,...
AmpliTech Group Announces Closing of $1.4 Million Registered Direct Offering
HAUPPAUGE, N.Y., Nov. 26, 2024 - PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW) (the “Company”), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, today announced it has closed on its previously announced registered direct offering for the sale...
ABQQ Reports FY 2024 Audited Financial Results, Introduces FY 2025 Outlook, Announces to Repurchase $5 Million of Shares by Year-End 2025
FY 2024 REVENUE INCREASED 125% TO A RECORD $3.3 MILLION FY 2024 REACH OPERATIONAL PROFITABILITY NET INCOME TO A RECORD $0.54 MILLION GUIDES FY 2025 REVENUE GROWTH OF APPROX. 150%; EPS RANGE OF $0.001 TO $0.002 ANNOUNCES INCREASE TO PREVIOUSLY COMMUNICATED SHARE REPURCHASE GOAL, TO REPURCHASE $5 MILLION OF SHARES BY YEAR END 2025 NEW YORK, Nov. 26, 2024 - PRISM MediaWire - AB International Group Corp. (OTC: ABQQ), an intellectual property (IP) and movie investment and licensing firm, announces...